Healthcare company PDI has welcomed Michael Yang as its new Senior Vice President of Research and Development. In his new role, Dr. Yang will oversee all of the company’s R&D business, with a focus on developing healthcare, food safety, and public health innovations.
“Michael brings a deep orientation to customer-inspired innovation and customer-valued technology solutions,” said PDI President and Chief Operating Officer Kent Davies. “As we continue to navigate the challenges of the current pandemic, PDI is even more focused on protecting the health of the customers and communities we serve. We are proud to strengthen PDI’s R&D expertise with Michael’s vast experience leading corporate technology strategy and new product portfolio development as we advance our growth strategy and rapidly respond to meet our customers’ evolving needs.”
Dr. Yang has experience consulting and advising a range of medical technology companies, helping them to grow their products and innovate new programs and processes. He has held senior R&D roles at global companies including Cardiovascular Systems, Johnson & Johnson, and Abbott Labs / St. Jude Medical, and most recently served as Vice President, Global Product Development and Program Management Office, Specialty Surgical Division, at Integra Lifesciences.
“Joining PDI at this crucial moment for the infection prevention market provides an exciting challenge and a timely opportunity to leverage my extensive product development experience to help further enhance the company’s portfolio and meet growing customer needs,” said Dr. Yang. “PDI’s commitment to customers and progressive approach to product and service innovation reinforce my enthusiasm for joining this unique infection prevention platform as it leads the fight against preventable infections in our communities.”